Frederic Legros, PhDCEO at ARTHEx BiotechSpeaker
Profile
Dr. Frédéric Legros is an established biotech leader with more than 15 years of Corporate & Business Development experience in the biotechnology industry. Between January 2017 and October 2022, he served as Chief Operating Officer of Dynacure, a company he co-founded. Prior to launching Dynacure, and until December 2016, Dr. Legros served as Vice President and Corporate Head of Business Development of Valneva SE, a biotech company listed on the French stock exchange. Dr. Legros studied biotechnology and received his Ph.D. in molecular biology from University of Paris 7. He also holds a business degree from NEOMA Business School, France.
Agenda Sessions
Recent Progress in the Treatment of Myotonic Dystrophy Type 1 (DM1), The Most Common Adult-onset Muscular Dystrophy
, 4:15pmView Session